Functional neuroanatomy of the endocannabinoid system

  title={Functional neuroanatomy of the endocannabinoid system},
  author={Mar{\'i}a Ruth Pazos and Estefan{\'i}a N{\'u}{\~n}ez and Cristina Benito and Rosa Mar{\'i}a Tol{\'o}n and Julián Romero},
  journal={Pharmacology Biochemistry and Behavior},

Figures from this paper

The Endocannabinoid System and Alzheimer’s Disease
Data obtained in vitro, as well as in animal models for this disease and in human samples seem to corroborate the notion that the activation of the ECS, through the use of agonists or by enhancing the endogenous cannabinoid tone, may induce beneficial effects on the evolution of this disease.
Application of Mass Spectrometry in Unravelling the Secrets of the Endocannabinoid System
This study identified significant variations in EC levels in specific regions of postmortem alcoholics' brains, which also correlated with other neurotransmitter systems from the same set of samples, and was the first laboratory to identify the two main endocannabinoids in Caenorhabditis elegans, a free living soil nematode that is widely used as a model organism in biological research.
An Overview on the Biochemistry of the Cannabinoid System
An overview of the present state-of-the-art of biochemistry of the endocannabinoid system is given to give an overview of their functions in the brain, their alterations in a variety of neurological and psychiatric pathologies, and the proposed therapeutic benefits in these diseases of new cannabinoid-related compounds that improve the pharmacological properties of classic cannabinoids.
The endocannabinoid system in gp120-mediated insults and HIV-associated dementia
Endocannabinoids in the retina: From marijuana to neuroprotection
  • S. Yazulla
  • Biology
    Progress in Retinal and Eye Research
  • 2008
Endocannabinoids and Energy Homeostasis
Acute or chronic administration of selective synthetic CB1 antagonists to overweight or obese individuals causes weight loss, reduced waist circumference, and an improved lipid and glycemic profile.
Endocannabinoid System and Synaptic Plasticity: Implications for Emotional Responses
Functional relevance of endocannabinoid-mediated plasticity within the framework of emotional responses is focused on.


The endocannabinoid system: a general view and latest additions
The latest ‘additions’ to the endocannabinoid system are reviewed together with earlier breakthroughs that have contributed to the present knowledge of the biochemistry and pharmacology of theendocannabinoids.
Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.
A more thorough characterization of the roles of endocannabinoids in health and disease will be necessary to define the significance ofendocannabinoid inactivation mechanisms as targets for therapeutic drugs.
Role of endogenous cannabinoids in synaptic signaling.
The synthetic pathways of endocannabinoids are discussed, along with the putative mechanisms of their release, uptake, and degradation, and the fine-grain anatomical distribution of the neuronal cannabinoid receptor CB1 is described in most brain areas, emphasizing its general presynaptic localization and role in controlling neurotransmitter release.
Brain monoglyceride lipase participating in endocannabinoid inactivation
The results suggest that hydrolysis by means of MGL is a primary mechanism for 2-AG inactivation in intact neurons, and not on the accumulation of anandamide, another endocannabinoid lipid.
Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study.
Cellular accumulation of anandamide: consensus and controversy
It is the view that a significant portion of the intracellular AEA in most cells is sequestered either by a protein or lipid compartment and that AEA sequestered in this manner does not equilibrate directly with the extracellular pool.
Control of the cell survival/death decision by cannabinoids
The neuroprotective effect of cannabinoids may have potential clinical relevance for the treatment of neurodegenerative disorders such as multiple sclerosis, Parkinson's disease, and ischemia/stroke, whereas their growth-inhibiting action on transformed cells might be useful for the management of malignant brain tumors.
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
It is reported that anandamide is produced in and released from cultured brain neurons in a calcium ion-dependent manner when the neurons are stimulated with membrane-depolarizing agents, indicating that multiple biochemical pathways may participate in an andamide formation in brain tissue.
A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation.